Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Disease Progression and VEGF[original query] |
|---|
| Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. Journal of the American Society of Nephrology : JASN 2006 Mar 17 (3): 823-30. Doi Kent, Noiri Eisei, Nakao Akihide, Fujita Toshiro, Kobayashi Shuzo, Tokunaga Katsus |
| The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans. Cytokine 2010 Aug 51 (2): 158-65. Song Ji Hyun, Kim Sang Gyun, Jung Sung-Ae, Lee Mi Kyoung, Jung Hyun Chae, Song In Su |
| A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies. Gynecologic oncology 2011 Jun 121 (3): 455-61. Usha Lydia, Sill Michael W, Darcy Kathleen M, Benbrook Doris M, Hurteau Jean A, Michelin David P, Mannel Robert S, Hanjani Parviz, De Geest Koen, Godwin Andrew |
| Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Mar 29 (9): 1140-5. Argiris Athanassios, Karamouzis Michalis V, Gooding William E, Branstetter Barton F, Zhong Shilong, Raez Luis E, Savvides Panayiotis, Romkes Marjor |
| Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma. International journal of cancer. Journal international du cancer 2012 Sep 131 (5): E636-42. Andersen Niels F, Vogel Ulla, Klausen Tobias W, Gimsing Peter, Gregersen Henrik, Abildgaard Niels, Vangsted Annette |
| Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Sep 19 (17): 4816-23. Galanis Evanthia, Anderson S Keith, Lafky Jackie M, Uhm Joon H, Giannini Caterina, Kumar Shaji K, Kimlinger Teresa K, Northfelt Donald W, Flynn Patrick J, Jaeckle Kurt A, Kaufmann Timothy J, Buckner Jan |
| Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients. Cancer 2014 Dec 120 (24): 3923-31. Derosa Lisa, Galli Luca, Orlandi Paola, Fioravanti Anna, Di Desidero Teresa, Fontana Andrea, Antonuzzo Andrea, Biasco Elisa, Farnesi Azzurra, Marconcini Riccardo, Francia Giulio, Danesi Romano, Falcone Alfredo, Bocci Gui |
| Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study. The Lancet. Oncology 2015 Jun 16 (6): 686-94. Konecny Gottfried E, Finkler Neil, Garcia Agustin A, Lorusso Domenica, Lee Paula S, Rocconi Rodney P, Fong Peter C, Squires Matt, Mishra Kaushal, Upalawanna Allison, Wang Yongyu, Kristeleit Rebec |
| VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients. Future oncology (London, England) 2016 Oct . Camerin Gabriela Ribeiro, Brito Angelo Borsarelli Carvalho, Vassallo José, Derchain Sophie Françoise Mauricette, Lima Carmen Silvia Pass |
| Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population. PloS one 2017 12 (8): e0183503. Ratnasari Neneng, Nurdjanah Siti, Sadewa Ahmad Hamim, Hakimi Mohammad, Yano Yoshihi |
| A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Jan . Jonasch E, Hasanov E, Corn P G, Moss T, Shaw K R, Stovall S, Marcott V, Gan B, Bird S, Wang X, Do K A, Altamirano P F, Zurita A J, Doyle L A, Lara P N, Tannir N |
| Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study). British journal of cancer 2018 6 119 (3): 330-338. Ruscito Ilary, Cacsire Castillo-Tong Dan, Vergote Ignace, Ignat Iulia, Stanske Mandy, Vanderstichele Adriaan, Glajzer Jacek, Kulbe Hagen, Trillsch Fabian, Mustea Alexander, Kreuzinger Caroline, Benedetti Panici Pierluigi, Gourley Charlie, Gabra Hani, Nuti Marianna, Taube Eliane T, Kessler Mirjana, Sehouli Jalid, Darb-Esfahani Silvia, Braicu Elena Ioa |
| Vascular Endothelial Growth Factor (VEGF) Gene Promoter Polymorphisms and Disease Progression in North Indian Cohort with Autosomal Dominant Polycystic Kidney Disease. International journal of molecular and cellular medicine 2017 6 (3): 164-173. Pandita Shewata, Maurya Deepshikha, Ramachandran Vijaya, Verma Jyotsna, Kohli Sudha, Saxena Renu, Verma Ishwar Chand |
| Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting. Translational oncology 2019 Mar 12 (3): 502-512. Ma Cheng-Jen, Huang Ching-Wen, Chang Tsung-Kun, Tsai Hsiang-Lin, Su Wei-Chih, Yeh Yung-Sung, Chen Po-Jung, Wang Jaw-Yu |
| Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study. Lung cancer (Amsterdam, Netherlands) 2020 Nov 151 20-24. Yamamoto N, Seto T, Nishio M, Goto K, Yamamoto N, Okamoto I, Yamanaka T, Tanaka M, Takahashi K, Fukuoka |
| Genetic Effects of Vascular Endothelial Growth Factor A (VEGF-A) and Its Association with Disease Progression in Breast Cancer Population of Saudi Arabia. Asian Pacific journal of cancer prevention : APJCP 2020 Jan 21 (1): 139-145. Albalawi Ibrahim Altedlawi, Mir Rashid, Abu Duhier F |
| Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels. Journal of hepatocellular carcinoma 2021 8 1281-1295. Cheng Jiamin, Li Yinyin, Wang Xiaohui, Dong Zheng, Chen Yan, Zhang Rui, Huang Jiagan, Jin Xueyuan, Yao Jianfei, Ge Aifang, Song Lele, Lu Yinying, Zeng Zh |
| Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World journal of gastroenterology 2021 10 27 (36): 6093-6109. Rah Bilal, Banday Manzoor Ahmad, Bhat Gh Rasool, Shah Omar J, Jeelani Humira, Kawoosa Fizalah, Yousuf Tahira, Afroze D |
| Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2229-2236. Lee Sunyoung, Shroff Rachna T, Makawita Shalini, Xiao Lianchun, Danner De Armas Anaemy, Bhosale Priya, Reddy Kavitha, Shalaby Ahmed, Raghav Kanwal, Pant Shubham, Wolff Robert A, Javle Mili |
| Analysis of endothelial gene polymorphisms in Spanish patients with vascular dementia and Alzheimer´s disease. Scientific reports 2023 8 13 (1): 13441. Raquel Manso-Calderón, Purificación Cacabelos-Pérez, M Dolores Sevillano-García, M Elisa Herrero-Prieto, Rogelio González-Sarmien |
| Evaluating TAB2, IKBKB, and IKBKG Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency. Medicina (Kaunas, Lithuania) 2025 1 60 (12): . Alvita Vilkeviciute, Enrika Pileckaite, Akvile Bruzaite, Dzastina Cebatoriene, Greta Gedvilaite-Vaicechauskiene, Loresa Kriauciuniene, Dalia Zaliuniene, Rasa Liutkevicie |
- Page last reviewed:Feb 1, 2024
- Content source: